Advanced search
Publication Cover
Pain Management Volume 9, 2019 - Issue 6
Submit an article Journal homepage
39,356
Views
0
CrossRef citations to date
0
Altmetric
Editorial

How Effective is Ketamine in the Management of Chronic Neuropathic Pain?

Jack Williams Shteamer1 Department of Anesthesiology, Emory University, Atlanta, GA30322, USAView further author information
,
Mayson Augustus Callaway1 Department of Anesthesiology, Emory University, Atlanta, GA30322, USAView further author information
,
Parth Patel1 Department of Anesthesiology, Emory University, Atlanta, GA30322, USAView further author information
&
Vinita Singh1 Department of Anesthesiology, Emory University, Atlanta, GA30322, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8103-1401View further author information
ORCID Icon
Pages 517-519 | Received 05 Aug 2019, Accepted 12 Aug 2019, Published online: 15 Oct 2019

References

  • Colloca L , LudmanT , BouhassiraDet.al Neuropathic pain. Nat. Rev. Dis. Primers3(1), 17002 (2017).
  • Wieseler-Frank J , MaierSF , WatkinsLR. Central proinflammatory cytokines and pain enhancement. Neurosignals14(4), 166–174 (2005).
  • Morgan CJA , MuetzelfeldtL , CurranHV. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study: the consequences of repeated ketamine use. Addiction105(1), 121–133 (2010).
  • Quibell R , PrommerEE , MihalyoM , TwycrossR , WilcockA. Ketamine*. J. Pain Symptom Manag.41(3), 640–649 (2011).
  • O’Brien SL , PangarkarS , PragerJ. The use of ketamine in neuropathic pain. Curr. Phys. Med. Rehabil. Rep.2(2), 128–145 (2014).
  • Zhang K , HashimotoK. An update on ketamine and its two enantiomers as rapid-acting antidepressants. Exp. Rev. Neurother.19(1), 83–92 (2019).
  • Peltoniemi MA , SaariTI , HagelbergNMet.al Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine. Basic Clin. Pharmacol. Toxicol.111(5), 325–332 (2012).
  • Michelet D , BrasherC , HorlinA-Let.al Ketamine for chronic non-cancer pain: a meta-analysis and trial sequential analysis of randomized controlled trials. Eur. J. Pain22(4), 632–646 (2018).
  • SPRAVATO™ (esketamine) . Janssen Pharmaceutical (2018). www.spravato.com/
  • Aroni F , IacovidouN , DontasI , PourzitakiC , XanthosT. Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug. J. Clin. Pharm.49(8), 957–964 (2009).
  • Wang X , DingX , TongYet.al Ketamine does not increase intracranial pressure compared with opioids: meta-analysis of randomized controlled trials. J. Anesth.28(6), 821–827 (2014).
  • Middela S , PearceI. Ketamine-induced vesicopathy: a literature review: ketamine and bladder. Int. J. Clin. Pract.65(1), 27–30 (2011).
  • Sigtermans MJ , van HiltenJJ , BauerMCRet.al Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain145(3), 304–311 (2009).
  • Kiefer R-T , RohrP , PloppaAet.al Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label Phase II study. Pain Med.9(8), 1173–1201 (2008).
  • Eichenberger U , NeffF , SveticicGet.al Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth. Analg.106(4), 1265–1273 (2008).
  • Bosma RL , ChengJC , RogachovAet.al Brain dynamics and temporal summation of pain predicts neuropathic pain relief from ketamine infusion. Anesthesiology129(5), 1015–1024 (2018).
  • Huge V , LauchartM , MagerlWet.al Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain. Eur. J. Pain14(4), 387–394 (2010).
  • Lynch ME , ClarkAJ , SawynokJ , SullivanMJL. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology103(1), 140–146 (2005).
  • Rabi J , MinoriJ , AbadH , LeeR , GittlerM. Topical ketamine 10% for neuropathic pain in spinal cord injury patients: an open-label trial. Int. J. Pharm. Compd.20(6), 517–520 (2016).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.